Behind the markets

Blog

TRADE ALERT: Lock in some profits on Apellis

I recommend selling half your shares in Apellis Pharmaceuticals, Inc (SYM: APLS)

March 2023 Issue: Schrodinger (SYM: SDGR)

A.I. has started to revolutionize drug discovery. You see, right now there are a about 6,000 genetic diseases known to mankind – Liver Disease…Diabetes…Skin Cancer...Heart Disease… You name it. 

UPDATE: Apellis Pharma (APLS) is still a “BUY”

A lot of folks have written in to ask if we think Apellis Pharmaceuticals (SYM: APLS) is a still buy. We recommended shares at $48.42 on January 13, and watched it explode to a high of $70.75, or, 46% in less than two months. Shares are now at $65, after the market sell-off.

January 2023 Issue: Apellis Pharmaceuticals (SYM: APLS)

An aging population is demanding better treatment in an effort to live longer lives (I'm beginning to count myself among that population). As we've detailed in these pages over the years, there's incredible new innovation in gene therapies, immuno-oncology, precision medicine, machine-learning drug discovery, and treatments for unmet medical needs, such as Geographic Apathy.

TRADE ALERT: Lock in some profits on Apellis

I recommend selling half your shares in Apellis Pharmaceuticals, Inc (SYM: APLS)

March 2023 Issue: Schrodinger (SYM: SDGR)

A.I. has started to revolutionize drug discovery. You see, right now there are a about 6,000 genetic diseases known to mankind – Liver Disease…Diabetes…Skin Cancer...Heart Disease… You name it. 

UPDATE: Apellis Pharma (APLS) is still a “BUY”

A lot of folks have written in to ask if we think Apellis Pharmaceuticals (SYM: APLS) is a still buy. We recommended shares at $48.42 on January 13, and watched it explode to a high of $70.75, or, 46% in less than two months. Shares are now at $65, after the market sell-off.

January 2023 Issue: Apellis Pharmaceuticals (SYM: APLS)

An aging population is demanding better treatment in an effort to live longer lives (I'm beginning to count myself among that population). As we've detailed in these pages over the years, there's incredible new innovation in gene therapies, immuno-oncology, precision medicine, machine-learning drug discovery, and treatments for unmet medical needs, such as Geographic Apathy.

Categories

Recent posts

Tags

Connect with Us

Get FREE Weekly Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*

You applied for

Hidden Market Profits

Platinum

$99

This field is for validation purposes and should be left unchanged.